Germany’s Education and Research minister does not expect a coronavirus vaccine to be broadly available before mid-2021.
Anja Maria-Antonia Karliczek spoke at a government news briefing Tuesday, where the country’s Health Minister Jens Spahn said that between 55 and 65% of its citizens would need to be vaccinated once the treatment has been found.
Spahn said he wanted to know more about the Russian vaccine, which has been approved by Moscow before Phase 3 trials.
“We would like to know more at times because there is not enough transparency,” Spahn said, adding that he was concerned about the speed at which it had been approved. “It is not about being first,” he added.
Spahn also said he was certain there was a willingness in the population to get tested and that Germany had enough information on Covid-19 to avoid a second lockdown.
“We don’t have the same situation as in March, because we know more,” Spahn said, explaining that distancing measures, washing hands and wearing a mask had helped prevent a second wave in the country.
“If we do this in the fall and winter, and we practice this, we will get through the fall and winter well,” he said.
Germany’s Ministry of Education and Research will also grant funds to biotechnology companies Curevac and BioNTech for the development of a coronavirus vaccine. Curevac will receive €252 million ($300 million) and BioNTech will receive €375 million.